Sars-Cov2 Envelope Proteine Mybiosource

SARS Envelope Antibody
24321-100ul 100ul
EUR 468

Human IgG antibody Laboratories manufactures the sars-cov2 envelope proteine mybiosource reagents distributed by Genprice. The Sars-Cov2 Envelope Proteine Mybiosource reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Mybiosource. Other Sars-Cov2 products are available in stock. Specificity: Sars-Cov2 Category: Envelope Group: Proteine Mybiosource

True north Cryobox 15mLBlue
PK10
EUR 212.4

True north Cryobox 50mLNatural
PK10
EUR 210

True north Cryobox 50mLBlue
PK10
EUR 210

True north Cryobox1.5/2mLNatural
PK10
EUR 162

True north Cryobox1.5/2.0mLGreen
PK10
EUR 162

SARS Envelope Antibody
100ul
EUR 468

SARS Envelope Antibody
100ul
EUR 468

Proteine Mybiosource information

Recombinant Coronavirus Envelope Protein (SARS-CoV)
P1534-50 50 µg
EUR 661.2

SARS-CoV Envelope Antibody
3533-002mg 0.02 mg
EUR 206.18
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.

SARS-CoV Envelope Antibody
3533-01mg 0.1 mg
EUR 523.7
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.

SARS Coronavirus Envelope Recombinant Protein
39-104 0.05 mg
EUR 556.8
Description: SARS Associated Coronavirus Envelope is a small membrane protein that takes major part in the life cycle of the virus. This protein is needed for the assembly, budding, creation of the envelope and pathogenesis. This protein contains 3 outer structural proteins, the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to assure viral entry thetarget cells. Accordingly, S-protein has a major part in virus infection cycle and is the mainly target of neutralizing antibodies.

SARS Coronavirus Envelope Recombinant Protein
39-118 0.1 mg
EUR 556.8
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

Recombinant Coronavirus Envelope Protein (SARS-CoV ENV;1-76)
P1503-10 10µg
EUR 187.2

Recombinant Coronavirus Envelope Protein (SARS-CoV ENV;1-76)
P1503-50 50µg
EUR 661.2

Recombinant SARS-CoV-2 envelope Protein with His and Avi Tag
E80005-1 100 ul
EUR 518.1

SARS Coronavirus Envelope (HSZ-Cc) Recombinant Protein
20-197 0.1 mg
EUR 726.9
Description: SARS Coronavirus Envelope (HSZ-Cc) Recombinant Protein

SARS Coronavirus Envelope (HSZ-Cc) Recombinant Protein
20-222 0.1 mg
EUR 726.9
Description: SARS Coronavirus Envelope (HSZ-Cc) Recombinant Protein

Recombinant SARS Associated Coronavirus Envelope
7-07117 100µg Ask for price

Recombinant SARS Associated Coronavirus Envelope
7-07118 500µg Ask for price

Recombinant SARS Associated Coronavirus Envelope
7-07119 1000µg Ask for price

Recombinant SARS Coronavirus Envelope, GST-Tagged
DAG532 1mg
EUR 2016

Recombinant (E.Coli) SARS Associated Coronavirus Envelope
RP-1418 100 ug
EUR 343.2

HIV 2 Envelope Protein
abx060590-1mg 1 mg
EUR 1888.8

HIV-2 Envelope Protein
20-abx260147
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg